Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

01 juin 2020 10h18 HE | Source: Tempus

Tempus Launches Prospective “Priority” Research Study and Increases Support for Oncology Research Initiatives Despite Pandemic Challenges

CHICAGO, June 01, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announces its...
31 mai 2020 10h30 HE | Source: Tempus

Tempus Launches New Precision Medicine-Driven Tests: Tempus|HRD and Tempus|TO

CHICAGO, May 31, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, announced the launch...
30 mai 2020 10h30 HE | Source: Tempus

Tempus Launches COVID-19-Specific Clinical and Research Initiatives for Oncology

CHICAGO, May 30, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, introduced a series of...
29 mai 2020 15h55 HE | Source: Tempus

Tempus’ TIME Trial™ Program Reaches Critical Scale and Operational Milestones

CHICAGO, May 29, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has reached a...
29 oct. 2019 11h00 HE | Source: Tempus

Tempus Announces the Appointment of Scott Gottlieb, MD, to Its Board of Directors

CHICAGO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announced that...
30 sept. 2019 11h00 HE | Source: Tempus

Nature Biotechnology Study Reveals That Tempus’ xT Platform Increases Cancer Patients’ Personalized Therapeutic Opportunities

CHICAGO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today published a...
03 sept. 2019 13h00 HE | Source: Tempus

Tempus Expands Its Management Team With the Appointment of Lauren Silvis as Senior Vice President of External Affairs

CHICAGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announced today the...
22 août 2019 12h00 HE | Source: Tempus

Tempus Expands Leadership Team With the Appointment of Joel Dudley, PhD, as Senior Vice President of Research

CHICAGO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announces the...
11 juin 2019 08h00 HE | Source: Tempus

Tempus and Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas

CHICAGO, June 11, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale announced today that...
03 juin 2019 10h30 HE | Source: Tempus

Tempus Announces (TIME) Trial Service, a New Integrated Molecular Evaluation that Leverages Artificial Intelligence to Rapidly Match Cancer Patients to Clinical Trials

CHICAGO, June 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announced today a...

Page suivante